2.2 Dosage Forms, Routes, and Administration Instructions

2.2 Dosage Forms, Routes, and Administration Instructions

Quick Answer: MTM technicians confirm each drug’s dosage form, route, and special administration instructions, then compare those facts to patient-reported use. Wrong form or route (crushing an ER tablet, swallowing a sublingual product whole) is a medication-related problem to flag—not something the technician “fixes” by changing therapy alone.

Strength and class tell you what drug and how much. Form and route tell you how the drug is delivered. Domain 1 explicitly includes dosage forms, routes of administration, and special administration instructions because many adherence and safety problems hide in technique, not in the fill history.

---

Core Dosage Forms Technicians Must Recognize

When building a PMR, record the form the patient actually uses. “Metoprolol” is incomplete if the patient uses metoprolol succinate ER tablets vs. metoprolol tartrate IR tablets—dose conversion and frequency differ and require pharmacist oversight.

---

Routes of Administration: Matching Intent to Use

Route abbreviations appear on labels and profiles; technicians should translate them into patient-friendly language during history interviews.

MTM technician scenario: wrong route use

A patient lists nitroglycerin “pills for chest pain.” The technician asks how they take it. The patient says they “swallow it with water when my chest hurts.” The product is nitroglycerin sublingual. Swallowing may delay or reduce the intended effect. The technician documents the technique problem and flags the pharmacist for urgent counseling—without redesigning anti-anginal therapy independently.

---

Special Administration Instructions That Drive MTM Flags

Special instructions are label or counseling points that change efficacy or safety if ignored. High-yield categories:

1. Do not crush / chew / split

Extended-release and enteric-coated products are common crush-risk items. Crushing can dump the full dose at once (dose dumping) or destroy acid protection. If a patient reports crushing pills for a feeding tube or “because they’re too big,” identify the form and escalate. Alternative forms (liquid, crushable IR, patch) are pharmacist/prescriber decisions.

2. Food and timing requirements

3. Device and technique instructions

• Inhalers: Prime new devices; breathe out fully; seal lips; inhale slowly or forcefully depending on MDI vs. DPI; hold breath; rinse mouth after inhaled corticosteroids.
• Insulin pens: Attach new needle, prime, dial correct units, inject into recommended sites, hold count, dispose of sharps safely.
• Patches: Apply to clean dry skin, rotate sites, press firmly, avoid heating pads, fold and dispose securely after removal.

Technique problems are adherence-related MRPs even when fills look perfect (PDC may be high while inhaler use is incorrect).

4. Combination and multi-step regimens

Some products require sequencing (for example, using a short-acting bronchodilator before a corticosteroid inhaler when directed). Others require reconstitution of oral suspensions with specific shake-and-measure steps. Confirm that caregivers know measuring devices are not interchangeable with household teaspoons.

---

Form Switches Are Not Automatic

Patients and plans often ask whether a tablet can become a capsule, liquid, or patch for convenience or cost. From a product-knowledge standpoint:

• Same active ingredient does not always mean same release profile or bioavailability.
• Topical and systemic forms are not interchangeable for the same indication without clinical review.
• “Take half a patch” or “cut the ER tablet” may be unsafe.

The technician’s job is to identify the opportunity or risk and route it to the pharmacist. Cost-saving form switches are covered in depth in Section 2.4; here, remember that form and route accuracy comes first.

---

Documentation Tips for Forms and Routes on the PMR

For each medication entry, aim for clarity a caregiver or covering clinician can follow:

1. Drug name + strength + form (for example, “pantoprazole 40 mg delayed-release tablet”).
2. Route in plain language (“by mouth,” “on the skin,” “inhaled”).
3. Special instructions the patient must follow (“do not crush,” “dissolve under the tongue,” “inject in the abdomen”).
4. Patient-reported technique issues noted separately as flags for the pharmacist’s MAP.

Scenario: patch wear-time error

A patient’s profile shows a fentanyl patch every 72 hours. The patient says they change it “every night because the pain comes back.” The technician recognizes a duration/administration mismatch, documents the reported wear interval, and escalates immediately. Shortened wear time can indicate uncontrolled pain, misuse risk, or misunderstanding—all pharmacist-managed clinical issues.

---

Quick Self-Check for Exam and Practice

Ask yourself for every medication on a practice list:

• What form is it?
• What route should it use?
• What special instruction would make this product fail if ignored?
• Did the patient describe use that matches the label?
• If not, did I flag the pharmacist with a clear note?

Technicians who master forms, routes, and administration instructions catch problems that pure refill data never show—and that is exactly the product-knowledge skill PTCB MTM Domain 1 targets.